These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35435272)

  • 61. Poor Prognostic Biochemical Markers Predicting Fatalities Caused by COVID-19: A Retrospective Observational Study From a Developing Country.
    Asghar MS; Haider Kazmi SJ; Khan NA; Akram M; Hassan M; Rasheed U; Ahmed Khan S
    Cureus; 2020 Aug; 12(8):e9575. PubMed ID: 32913691
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis.
    Malik P; Patel U; Mehta D; Patel N; Kelkar R; Akrmah M; Gabrilove JL; Sacks H
    BMJ Evid Based Med; 2021 Jun; 26(3):107-108. PubMed ID: 32934000
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of Patients with Major Fractures with and without COVID-19 Infection.
    Cansabuncu G; Akalin Y; Çevik N; Duran M; Öztürk A
    Acta Chir Orthop Traumatol Cech; 2022; 89(2):139-145. PubMed ID: 35621405
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Predictors of Effectiveness of Anakinra in Systemic Juvenile Idiopathic Arthritis.
    Saccomanno B; Tibaldi J; Minoia F; Bagnasco F; Pistorio A; Guariento A; Caorsi R; Consolaro A; Gattorno M; Ravelli A
    J Rheumatol; 2019 Apr; 46(4):416-421. PubMed ID: 30647180
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial.
    Srivastava A; Rengaraju M; Srivastava S; Narayan V; Gupta V; Upadhayay R
    Trials; 2021 Feb; 22(1):130. PubMed ID: 33573696
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Coagulation profile and correlation between D-dimer, inflammatory markers, and COVID-19 severity in an Indonesian national referral hospital.
    Sukrisman L; Sinto R
    J Int Med Res; 2021 Nov; 49(11):3000605211059939. PubMed ID: 34796762
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials.
    Martins-Filho PR; do Nascimento-Júnior EM; Barreto-Alves JA; Fakhouri R; Ferreira LC
    Eur J Clin Pharmacol; 2022 Nov; 78(11):1813-1821. PubMed ID: 36066651
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
    Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
    Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study.
    Cavalli G; De Luca G; Campochiaro C; Della-Torre E; Ripa M; Canetti D; Oltolini C; Castiglioni B; Tassan Din C; Boffini N; Tomelleri A; Farina N; Ruggeri A; Rovere-Querini P; Di Lucca G; Martinenghi S; Scotti R; Tresoldi M; Ciceri F; Landoni G; Zangrillo A; Scarpellini P; Dagna L
    Lancet Rheumatol; 2020 Jun; 2(6):e325-e331. PubMed ID: 32501454
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study.
    Aomar-Millán IF; Salvatierra J; Torres-Parejo Ú; Faro-Miguez N; Callejas-Rubio JL; Ceballos-Torres Á; Cruces-Moreno MT; Gómez-Jiménez FJ; Hernández-Quero J; Anguita-Santos F
    Intern Emerg Med; 2021 Jun; 16(4):843-852. PubMed ID: 33400157
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of anakinra in severe COVID-19: A case report.
    Filocamo G; Mangioni D; Tagliabue P; Aliberti S; Costantino G; Minoia F; Bandera A
    Int J Infect Dis; 2020 Jul; 96():607-609. PubMed ID: 32437934
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab.
    Figuero-Pérez L; Olivares-Hernández A; Escala-Cornejo RA; Terán-Brage E; López-Gutiérrez Á; Cruz-Hernández JJ
    Reumatol Clin (Engl Ed); 2021 Dec; 17(10):559-561. PubMed ID: 34823820
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The predictive role of biomarkers for mortality in COVID-19 patients.
    Savrun A; Aydin IE; Savrun ST; Karaman U
    Trop Biomed; 2021 Sep; 38(3):366-370. PubMed ID: 34508345
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association of serum C-reactive protein (CRP) and D-dimer concentration on the severity of COVID-19 cases with or without diabetes: a systematic review and meta-analysis.
    Debi H; Itu ZT; Amin MT; Hussain F; Hossain MS
    Expert Rev Endocrinol Metab; 2022 Jan; 17(1):83-93. PubMed ID: 34781810
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
    Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
    Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety.
    Hong D; Yang Z; Han S; Liang X; Ma K; Zhang X
    Drug Des Devel Ther; 2014; 8():2345-57. PubMed ID: 25473268
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis.
    Volfovitch Y; Tsur AM; Gurevitch M; Novick D; Rabinowitz R; Mandel M; Achiron A; Rubinstein M; Shoenfeld Y; Amital H
    Immunol Res; 2022 Dec; 70(6):817-828. PubMed ID: 36222965
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effectiveness and adverse effects of anakinra in treatment of rheumatoid arthritis: a systematic review.
    Bedaiwi MK; Almaghlouth I; Omair MA
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7833-7839. PubMed ID: 34982445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.